Stock BRIACELL THERAPEUTICS CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Briacell Therapeutics Corp Toronto S.E.

Equities

CA10778Y1043

Chart calendar Briacell Therapeutics Corp

69cb40fa380d02217cc600c9908.On-4taPNQii8P_yaQCKTnhBNi1_XHFfUOhsJG7--K5I.fheJ5ZP0NkD-daz1EXTf_GU4yQqkVWfiaShDYs-IavpvNY_v1ooDbekMyA~2d7a8a885b832bc12b9b012e010f1426

Upcoming events on Briacell Therapeutics Corp

23/10/2024 Q4 2024 Earnings Release (Projected)
10/12/2024 Q1 2025 Earnings Release (Projected)
26/03/2025 Q2 2025 Earnings Release (Projected)
09/12/2025 Q1 2026 Earnings Release (Projected)

Past events on Briacell Therapeutics Corp

03/06/2024 17:30 American Society of Clinical Oncology Meeting - Abstract No : 1022
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No : TPS1137
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No : 1087
10/04/2024 17:00 American Association for Cancer Research Meeting - Abstract No:6753
09/04/2024 17:00 American Association for Cancer Research Meeting - Abstract No:CT204
09/04/2024 17:00 American Association for Cancer Research Meeting - Abstract No:CT206
18/03/2024 21:05 Q2 2024 Earnings Release
30/01/2024 15:00 Annual General Meeting
14/12/2023 22:10 Q1 2024 Earnings Release
07/12/2023 18:00 San Antonio Breast Cancer Symposium
06/12/2023 23:00 San Antonio Breast Cancer Symposium
06/12/2023 18:00 San Antonio Breast Cancer Symposium
03/11/2023 16:00 Society for Immunotherapy of Cancer Meeting - Abstract Number: 419
26/10/2023 15:00 Investor Meeting - Key Opinion Leader
25/10/2023 17:00 Q4 2023 Earnings Release
04/09/2023 Spin off
18/08/2023 15:00 Extraordinary Shareholders Meeting - Restructuring Vote
17/04/2023 18:30 American Association for Cancer Research Meeting - Abstract Number: CT143
17/04/2023 14:00 American Association for Cancer Research Meeting - Abstract Number: 2310
17/04/2023 14:00 American Association for Cancer Research Meeting - Abstract Number: 2310

Annual results

Fiscal PeriodJuly 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-15,3
-15,7
2.58%		-23,3
-21,9
-6.06%
-34,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-26,8
-15,7
-70.86%		-20,3
-24,2
15.94%
-24,5

Net income
Million USD		Released
Forecast
Spread 		-0,43


-26,8
-15,7
-70.86%		-20,3
-24,2
15.94%
-24,5

EPS
USD		Released
Forecast
Spread 		-0,09


-1,73
-1,02
-69.61%		-1,30
-1,56
16.4%
-1,39

Announcement Date28/10/2127/10/2225/10/23-

Quarterly results

Fiscal PeriodJuly 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-3,93
-2,40
-63.85%		-4,84
-3,31
-46.43%		-4,23
-4,61
8.38%		-5,40
-5,20
-3.91%		-4,49
-5,46
17.87%		-5,68
-5,57
-1.97%		-7,71
-6,36
-21.16%		-8,50
-8,00
-6.29%		-9,83
-8,40
-17.02%
-7,90


-8,20

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-3,87
-2,45
-57.76%		-4,84
-3,31
-46.43%		-15,7
-4,61
-241.42%		-1,11
-5,20
78.72%		-11,9
-5,46
-117.52%		-4,90
-5,47
10.46%		-2,42
-6,26
61.36%		5,96
-2,80
312.82%		-11,3
-3,20
-254.18%
-9,40


-9,70

Net income
Million USD		Released
Forecast
Spread 		-3,87
-2,45
-57.76%		-4,84
-3,31
-46.43%		-15,7
-4,61
-241.42%		-1,11
-5,20
78.72%		-11,9
-5,46
-117.52%		-4,90
-5,47
10.46%		-2,42
-6,26
61.36%		6,00
-2,80
314.34%		-11,3
-3,20
-252.96%
-9,40


-9,70

EPS
USD		Released
Forecast
Spread 		-0,24
-0,17
-45.45%		-0,32
-0,21
-52.38%		-1,02
-0,31
-234.43%		-0,07
-0,33
78.79%		-0,77
-0,36
-116.9%		-0,32
-0,36
9.86%		-0,14
-0,40
64.56%		0,36
-0,18
300%		-0,71
-0,20
-255%
-0,55


-0,46

Announcement Date14/03/2213/06/2227/10/2214/12/2215/03/2314/06/2325/10/2314/12/2318/03/24--

Upcoming sector events for Briacell Therapeutics Corp

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Briacell Therapeutics Corp

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. BCT Stock
  4. Stock
  5. Calendar Briacell Therapeutics Corp
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW